Skip to main content
Clinical Trials/IRCT20171120037376N1
IRCT20171120037376N1
Recruiting
Phase 2

A clinical trial to compare the effectiveness of spironolactone with the standard treatment in right ventricular function in group 1 pulmonary hypertension patients

Vice Chancellor for Research, Mashhad University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with group 1 pulmonary hypertension; aged between 12 and 76 years.
  • Exclusion criteria: Eisenmenger's syndrome; congenital diseases; scleroderma, thalassemia, systemic disease, cirrhosis, cor pulmonale, renal failure; frequent readmission and receiving inotropic therapy; left systolic dysfunction; mental disabilities; pulmonary disease of asthma; and unwillingness to follow up.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials